Staar Surgical Stock Buy Hold or Sell Recommendation
| STAA Stock | USD 17.05 0.36 2.07% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding STAAR Surgical is 'Cautious Hold'. Macroaxis provides STAAR Surgical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding STAA positions.
Check out STAAR Surgical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide. In addition, we conduct extensive research on individual companies such as STAAR and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
STAAR |
Execute STAAR Surgical Buy or Sell Advice
The STAAR recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on STAAR Surgical. Macroaxis does not own or have any residual interests in STAAR Surgical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute STAAR Surgical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
STAAR Surgical Trading Alerts and Improvement Suggestions
| STAAR Surgical generated a negative expected return over the last 90 days | |
| STAAR Surgical has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 313.9 M. Net Loss for the year was (20.21 M) with profit before overhead, payroll, taxes, and interest of 239.58 M. | |
| STAAR Surgical has a strong financial position based on the latest SEC filings | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: STAAR Surgical Shares Bought by Jupiter Asset Management Ltd. |
STAAR Surgical Returns Distribution Density
The distribution of STAAR Surgical's historical returns is an attempt to chart the uncertainty of STAAR Surgical's future price movements. The chart of the probability distribution of STAAR Surgical daily returns describes the distribution of returns around its average expected value. We use STAAR Surgical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of STAAR Surgical returns is essential to provide solid investment advice for STAAR Surgical.
| Mean Return | -0.49 | Value At Risk | -5.18 | Potential Upside | 6.86 | Standard Deviation | 4.55 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of STAAR Surgical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
STAAR Stock Institutional Investors
| Shares | Yunqi Capital Ltd | 2024-12-31 | 767.4 K | Millennium Management Llc | 2024-12-31 | 759.1 K | Defender Capital, Llc. | 2024-12-31 | 701.6 K | Geneva Capital Management | 2024-12-31 | 662.8 K | Northern Trust Corp | 2024-12-31 | 521.9 K | Palo Alto Investors, Llc | 2024-12-31 | 500.8 K | Charles Schwab Investment Management Inc | 2024-12-31 | 444.3 K | Bank Of America Corp | 2024-12-31 | 439.5 K | Artisan Partners Limited Partnership | 2024-12-31 | 439 K | Broadwood Capital Inc | 2024-12-31 | 10.8 M | Blackrock Inc | 2024-12-31 | 8.2 M |
STAAR Surgical Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 32.5M | 47.3M | (113.2M) | 96.6M | (38.9M) | (36.9M) | |
| Free Cash Flow | 12.5M | 30.3M | 17.6M | (3.6M) | (7.7M) | (7.3M) | |
| Depreciation | 3.1M | 3.6M | 4.5M | 5.1M | 6.9K | 6.5K | |
| Other Non Cash Items | 3.4M | 2.1M | 2.3M | 2.2M | 10.5M | 11.1M | |
| Capital Expenditures | 8.4M | 13.6M | 18.1M | 18.2M | 23.4M | 24.6M | |
| Net Income | 5.9M | 24.5M | 39.0M | 21.3M | (20.2M) | (19.2M) | |
| End Period Cash Flow | 152.5M | 199.7M | 86.5M | 183.0M | 144.2M | 151.4M | |
| Change To Inventory | (1.4M) | 66K | (7.9M) | (14.4M) | (10K) | (10.5K) | |
| Net Borrowings | (2.0M) | (515K) | (1.6M) | (126K) | (113.4K) | (119.1K) | |
| Change To Netincome | 8.9M | 14.1M | 18.2M | 21.3M | 24.5M | 25.7M | |
| Investments | (8.4M) | (13.6M) | (156.4M) | 74.3M | (59.2M) | (56.3M) |
STAAR Surgical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to STAAR Surgical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that STAAR Surgical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a STAAR stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.47 | |
β | Beta against Dow Jones | 0.21 | |
σ | Overall volatility | 4.65 | |
Ir | Information ratio | -0.09 |
STAAR Surgical Volatility Alert
STAAR Surgical exhibits very low volatility with skewness of -2.06 and kurtosis of 11.37. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure STAAR Surgical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact STAAR Surgical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.STAAR Surgical Fundamentals Vs Peers
Comparing STAAR Surgical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze STAAR Surgical's direct or indirect competition across all of the common fundamentals between STAAR Surgical and the related equities. This way, we can detect undervalued stocks with similar characteristics as STAAR Surgical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of STAAR Surgical's fundamental indicators could also be used in its relative valuation, which is a method of valuing STAAR Surgical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare STAAR Surgical to competition |
| Fundamentals | STAAR Surgical | Peer Average |
| Return On Equity | -0.0516 | -0.31 |
| Return On Asset | -0.0155 | -0.14 |
| Profit Margin | (0.06) % | (1.27) % |
| Operating Margin | (0.57) % | (5.51) % |
| Current Valuation | 650.23 M | 16.62 B |
| Shares Outstanding | 49.33 M | 571.82 M |
| Shares Owned By Insiders | 0.50 % | 10.09 % |
| Shares Owned By Institutions | 99.50 % | 39.21 % |
| Number Of Shares Shorted | 4.35 M | 4.71 M |
| Price To Earning | 460.83 X | 28.72 X |
| Price To Book | 2.12 X | 9.51 X |
| Price To Sales | 2.68 X | 11.42 X |
| Revenue | 313.9 M | 9.43 B |
| Gross Profit | 239.58 M | 27.38 B |
| EBITDA | (5.72 M) | 3.9 B |
| Net Income | (20.21 M) | 570.98 M |
| Cash And Equivalents | 202.49 M | 2.7 B |
| Cash Per Share | 4.22 X | 5.01 X |
| Total Debt | 38.74 M | 5.32 B |
| Debt To Equity | 0.10 % | 48.70 % |
| Current Ratio | 6.37 X | 2.16 X |
| Book Value Per Share | 8.06 X | 1.93 K |
| Cash Flow From Operations | 15.72 M | 971.22 M |
| Short Ratio | 3.35 X | 4.00 X |
| Earnings Per Share | (0.41) X | 3.12 X |
| Price To Earnings To Growth | (4.89) X | 4.89 X |
| Target Price | 18.67 | |
| Number Of Employees | 1.16 K | 18.84 K |
| Beta | 0.66 | -0.15 |
| Market Capitalization | 841 M | 19.03 B |
| Total Asset | 509.52 M | 29.47 B |
| Retained Earnings | (67.58 M) | 9.33 B |
| Working Capital | 297.63 M | 1.48 B |
Note: Disposition of 10000 shares by Farrell Stephen C of STAAR Surgical at 5.54 subject to Rule 16b-3 [view details]
STAAR Surgical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as STAAR . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About STAAR Surgical Buy or Sell Advice
When is the right time to buy or sell STAAR Surgical? Buying financial instruments such as STAAR Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having STAAR Surgical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Funds Thematic Idea Now
Money Funds
Funds or Etfs that invest most if their asset in companies from financial sector such as commercial banks, insurance companies, investment funds, and real estate. The Money Funds theme has 19 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out STAAR Surgical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.018 | Earnings Share (0.41) | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.